ArticleFrontiers in oncology2026
Morphology-guided attention networks for explainable skin cancer detection under clinical uncertainty.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate and reliable skin cancer detection from dermoscopic images remains challenging due to large visual variability, overlapping lesion appearances, and inherent clinical uncertainty. To address these issues, this work proposes a morphology-guided attention framework for explainable and uncertainty-aware skin lesion classification. The system integrates lesion segmentation to preserve clinically meaningful morphological structures, followed by an attention-based classification network that emphasizes diagnostically relevant regions while suppressing background artifacts. Visual attention and attribution maps are generated to provide transparent explanations aligned with established dermoscopic criteria. In addition, an uncertainty estimation module is incorporated to quantify prediction confidence and identify ambiguous or out-of-distribution cases for safe clinical triage. The proposed approach is evaluated on publicly available dermoscopic datasets and achieves classification accuracy 99.12% with a recall rate above 99% for malignant lesions, demonstrating strong sensitivity for early cancer detection. Experimental results show that morphology-guided attention improves both classification performance and interpretability compared to conventional deep learning models. Furthermore, uncertainty-aware predictions enhance model reliability by reducing overconfident errors in challenging cases. These findings indicate that the proposed framework offers a robust, explainable, and clinically relevant solution for automated skin cancer screening under real-world conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.